Search Within

Connie Wing-Ching Lee Batlevi

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (44)
  2. Journal Article (19)
  3. Research Letter (3)
  4. Correspondence (1)
Groups
  1. CTCR Scholars (67)
  2. Center for Hematologic Malignancies (67)
  3. Department of Medicine (67)
  4. Hematologic Malignancies, Division of (67)
  5. Lymphoma (67)
  6. MSK Grad Students (67)

More Groups

People
  1. Maria Palomba (63)
  2. Gunjan Shah (42)
  3. Miguel-Angel Perales (40)
  4. Michael Scordo (39)
  5. Parastoo Dahi (39)
  6. Craig Sauter (37)

More People

Years
  1. 2023 (4)
  2. 2022 (14)
  3. 2021 (15)
  4. 2020 (17)
  5. 2019 (16)
  6. 2018 (1)
Publications
  1. Blood (28)
  2. Blood Advances (6)
  3. Transplantation and Cellular Therapy (5)
  4. Biology of Blood and Marrow Transplantation (4)
  5. Blood Cancer Journal (4)
  6. Hematological Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (34)
  2. Elsevier Inc. (12)
  3. Nature Publishing Group (8)
  4. Wiley Blackwell (4)
  5. American Society of Clinical Oncology (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (67)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma
    Journal Article

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; DeSelm, C.; Batlevi, C.; Dahi, P. B.; Giralt, S.; Noy, A. M.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical neurological features and electrographic patterns of patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene ciloleucel at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Sequeira, A.; Mao, D.; Chen, X.; Avila, E.; Mead, E.; Sauter, C. S.; Palomba, M. L.; Dahi, P. B.; Batlevi, C. L.; Shah, G.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save